nidhe taylor

AI for Drug Discovery Market Expected to Witness a Sustainable Growth over 2027

2020-01-06T12:22:26.655Z

Artificial intelligence (AI) have successfully used in various areas, which include computer vision, speech recognition, and natural language processing. However, AI is now increasingly getting into the areas that need substantial domain expertise. The fields are biology, chemistry, and it also helps to lower the cost of drug discovery and drug development. Artificial intelligence is used in the drug discovery and development by growing the level of understanding of complex biology, managing drug design, and by assisting other more ordinary elements of pharmaceutical R&D and regulatory affairs. The application of AI decreases researches and development gap in the drug manufacturing process, and it helps in the targeted manufacturing of the drugs.

AI offers numerous benefits in the process of drug discovery and other developments. Some of the advantages of AI techniques include, it enhances the value of the product, makes the drug discovery faster, inexpensive, and more productive.

Various factors are owing to which the adoption rate of AI in the drug discovery has been rising. Some of them include increasing pressure on the drug manufacturer to decrease drug price, a growing number of partnerships and collaborations in the various industries.

Rising Pressure on the Drug Manufacturer to Decrease Drug Price

The global drug manufacturers are under pressure to reduce drug prices by the government of the countries. In 2019, approximately sixty pharmaceutical companies got removed due to increasing the list prices of around 300 drugs. And more drug manufacturers are anticipated to follow suit in recent years quietly.

In Europe, France, Germany, Sweden, and the United Kingdom have developed a set of government controls to limit the rise of prescription drug prices and expenditures.

The rise in drug expenditure has also been growing due to the use of newer and more expensive drugs. The new medicines have higher average prices than the medications used previously, the pressure on its budgets are growing even when consumption levels remain constant. So, these new products that range from advanced treatments to modest improvements over the existing products, which can strain drug budgets when they replace less expensive medications.

Growing Number of Partnerships and Collaborations

Major players have come in the market by evolving innovative devices. The shift in technology provides an aim for the market players to improve their product. The innovative product assists in enhancing the better results for health and live a better life. The presence of significant players in the market makes it consolidated that are conducting various developmental activities for the AI in the drug discovery. The multiple companies of AI and pharmaceuticals are coming together for partnerships and other activities to enhance the products and systems in the market.

For instance, in January 2019, Recursion collaborated with Takeda Pharmaceutical for recognizing novel preclinical candidates for rare diseases. The aim of this partnership enabled Takeda pharmaceutical to evaluate the preclinical and clinical compounds in above 60 different indications, with new therapeutic candidates identified in more than half-a-dozen diseases. So, Takeda utilized the option for drug candidates in two rare diseases, and the two companies have extended the partnership. Moreover, in January 2019, Recursion signed a licensing deal with the Ohio State Innovation Foundation (OSIF). The foundation has acquired the rights of OSU-HDAC42, a clinical stage compound that which is developed by Recursion for neurofibromatosis type 2 (NF2), which is a rare tumor syndrome.

Furthermore, in January 2019, Atomwise signed a strategic alliance with a contract research organization (CRO) Charles River Laboratories International. Atomwise will support CRL’s discovery and lead optimization.

And in July 2017, GlaxoSmithKline signed a US$ 43 million deal with Excientia for stimulating drug development. GSK indicated it would use AI to discover novel and select molecules for up to 10 disease-related targets across various therapeutic areas. Additionally, in December 2016, IBM and Pfizer signed the latest collaboration for helping to identify next-generation cancer treatments. Pfizer utilizes the computer developed by IBM’s Watson to support drug discovery for cancer immunotherapies. Thus, innovative steps and collaboration undertook by new entrants as well as established market players to improve the quality and efficacy of AI in drug discovery will help in the growth of the market soon.

Challenges in Machine Learning for Drug Discovery

Along with the various benefits offered by AI solutions in the drug discovery industry, there are also particular challenges. The safety of the drug is among the significant challenges faced in the drug discovery process. The information about the effects of drugs and calculating their side effects is a difficult job. Scientists and engineers from Roche and Pfizer are obtaining information from clinical data with the help of AI. Interpretation of this data in the context of drug safety is an active area of research.

The clinical trials are the most expensive stage of drug development. For reducing the costs, it is vital to use the previously gained experience of clinical trials in the early stages of drug development. The safety of the drug discovery is done in by the biomedical data from research experiments should be examined and interpreted with the help of machine learning for predicting a drug’s effects and side effects. And secondly, the data from clinical trials investigated with machine learning supports the explanation of biological data. The mentioned approaches have made it possible to design better preclinical experiments for the most effective therapies with minimal side effects. To decrease the risks associated with data storage, organizations have developed advanced AI systems that are capable of enhancing drug discovery.

Nevertheless, rapidly growing technological advancements in drug discovery are helping industry players to introduce more products. Products that made with the incorporation with technology have shown more valuable benefits, and therefore, the demand is increasing among the patients that will assist them in managing their diseases. Additionally, the support from the regulatory bodies has fostered the innovation in the drug discovery, and the significant growth in product manufacturing. For instance, in July 2016, Innoplexus launched blockchain platform, iPlexus, to increase the amount of data available for drug research and discovery. The latest iPlexus is the first that will allow researchers to upload and license unpublished data on the blockchain to facilitate collaboration, decrease duplicative work, and enhance the speed of innovation. Thus, product innovation of drug discovery has offered more effective and personalized management of the various rare diseases. Hence, owing to the several driving factors, the AI for the drug discovery market is expected to experience profitable growth in the future.

Get Sample PDF@ https://www.theinsightpartners.com/sample/TIPRE00004177/

Electrosurgical Devices Market Insight on the Analysis by Essential Factors and Trends In Industry by 2027

2019-10-14T15:31:08.069Z

The global electrosurgical devices market accounted to US$ 4,828.4 Mn in 2017 and is expected to grow at a CAGR of 6.8% during the forecast period 2018 - 2025, to account to US$ 8,000.9 Mn by 2025.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, rise in number of surgical procedures as well as FDA approvals obtained by key players in the market.

Market Insights

Rising Demand for Minimally Invasive Surgeries

Minimally invasive surgery (MIS) has the advantages which include less tissue injury, reduced pain, faster oral intake, smaller hospitalization and better cosmetic appearance when compared with open surgery. The benefits as well as the accuracy being offered by minimally invasive surgeries are expected to drive the market for electrosurgical devices. In laparoscopy, the surgical scars are smaller, hospital stays are shorter and the incisions created are much smaller, enabling faster healing and recovery. In recent days laparoscopy is being used widely for bariatric surgery and is also economical compared to the traditional surgery method.

Growing Geriatric Population & Associated Rise in Chronic Diseases

The elderly population is defined as group of people aged 65 and over. Population ageing is poised to become one of the most significant social transformations of the twenty-first century. The number of geriatric population has been increasing rapidly across the globe. According to the data published by the United Nations, in 2017, there were an estimated 962 million people aged 60 or over in the world, which comprised of 13 per cent of the global population. The geriatric population is estimated to grow at a rate of 3% every year. According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%).

Company Profiles

Olympus Corporation
Medtronic
Ethicon US, LLC
Boston Scientific Corporation
B. Braun Melsungen AG
CONMED Corporation
Erbe Elektromedizin GmbH
Kirwan Surgical Products, LLC
BOVIE MEDICAL
Parkell, Inc.

Product Insights

The global electrosurgical devices market by type was led by electrosurgical generators segment. In 2017, the electrosurgical generators segment held a largest market share of 33.0% of the electrosurgical devices market, by product. The electrosurgical generators segment is expected to dominate the market in 2025 since they are the basic component in an electrosurgical device.

Application Insights

The electrosurgical devices market by application was segmented into general surgery, gynecology, urology, gastroenterology, arthroscopy and others. The general surgery segment held the largest share of the market, by application. The general surgery is likely to dominate in the forecast period owing to to the rising demand for the procedure.

ELECTROSURGICAL DEVICES - MARKET SEGMENTATION

By Product

Electrosurgical Generators
Active Electrodes
Dispersive Electrodes
Other

By Application

General Surgery
Gynecology
Urology
Gastroenterology
Arthroscopy
Others

By Geography

• North America

U.S.
Canada
Mexico

• Europe

France
Germany
UK

• Asia Pacific (APAC)

China
India
Japan

• Middle East & Africa (MEA)

Saudi Arabia
South Africa
UAE

• South America (SAM)

Brazil

Strategic Insights

Acquisitions and product launches were observed as the most adopted strategy in global electrosurgical devices industry. Few of the recent product launch and acquisitions and others are listed below:

2018: In May, 2018, Olympus launched and received the approval for the ESG-300 Electrosurgery Generator. This is the latest generation of electrosurgical devices developed majorly for GI and pulmonary.

2017: In January, 2018, Ethicon acquired Megadyne Medical Products, Inc., a company manufacturing electrosurgical tools used in operating rooms. The acquisition has helped in developing better electrosurgical tools to a broader market through Ethicon’s extended global network.

Magnetic Resonance Imaging Market Deep Analysis by Production Overview and Insights 2018-2027

2019-10-08T12:42:09.776Z

The global magnetic resonance imaging market is expected to reach US$ 7,955.1 Mn in 2025 from US$ 5,913.6 in 2017. The magnetic resonance imaging market is estimated to grow with a CAGR of 3.8% from 2018-2025.

Magnetic resonance imaging market is segmented by product into field strength, architecture, application, and end user. On the basis of field strength, the market is segmented into low field MRI systems, high-field MRI systems, and ultra-high-field MRI systems. The architecture segment of the magnetic resonance imaging market is segmented into open MRI systems, and closed MRI systems. The application segment of the magnetic resonance imaging market is segmented into open cardiology, oncology, gastroenterology, and neurology, musculoskeletal and other applications. The end user segment of the magnetic resonance imaging market is segmented into hospitals, ambulatory surgical centers, and diagnostic centers.

Magnetic resonance imaging (MRI) is a scan which utilizes strong magnetic fields and radio waves for producing detailed images of the inside of the body. The MRI scanner is a large tube that contains powerful magnets, the patient lies inside the tube during the scan. An MRI scan can be used to examine almost any part of the body, which include brain and spinal cord, bones and joints, breasts, heart and blood vessels, and others. The report would be of an interest to various stakeholders operating in the magnetic resonance imaging market. These stakeholders include hospitals, diagnostic centers, research institutes, academic institutes, medical device suppliers, market research and consulting firms.

The objective of the study is to describe, define, and forecast the magnetic resonance imaging market by field strength, architecture, application, end user, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting magnetic resonance imaging market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key magnetic resonance imaging manufacturing companies along with their SWOT analysis and market strategies.

The major players operating in the magnetic resonance imaging market include General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Esaote SpA, FONAR, Hitachi, Ltd., Aspect Imaging, Neusoft Corporation and Time Medical Holding.

For instance, in April 2017, Philips introduced the latest MR solution neurology-focused MultiBand SENSE. The launch of the product helped in the faster diagnosis of the diseases. And the launch expanded the geographical presence of the company in global magnetic resonance imaging market.

Insulin Pumps Market 2019-2025 Industry Significant Trend, Opportunities, Key Players

2019-09-20T11:41:34.823Z

The global insulin pumps market is expected to reach US$ 8,264.01 Mn in 2025 from US$ 3,822.44 Mn in 2017. The market is estimated to grow with a CAGR of 10.5% from 2016-2025.

In recent years, there has been a significant rise in rate of diabetic patients that help to grow the market. The increasing prevalence of diabetes is one of the largest global health condition of the 21st century, with no specialized cure. Each year there is a rise in people with this condition, which can result in life-changing complications. For instance, according to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. The increase in the disease prevalence is around 35% during the forecast period. However, the increasing cost of insulin pumps is expected to act as major challenges hindering the market growth. On the other hand, rising medical tourism in the countries is expected to provide opportunistic scenario for the growth of global insulin pumps market to a significant rate.'

Increasing prevalence of type I and type II diabetes increasing the demand for the development of new drugs or medical devices for the treatment. The leading players are also help to propel the growth of the market. For instance, Insulet Corporation is one of the global leading player that engaged in the provision to develop and produce the insulin delivery systems that are designed for people with insulin-dependent diabetes in the US and overseas. In the June 2018, the company received FDA 510(k) clearance for the Omnipod DASHTM Insulin Management System (Omnipod DASH). This clearance set up the foundation for a stable pace of innovation that enables Insulet to allow users to enjoy simplicity, healthier lives, and freedom swith their differentiated technology. Moreover, the system signifies the latest technology update pushing Insulet’s Omnipod closer to the Horizon Hybrid Closed Loop System that is evolving in the clinical trials.

The other key players operating in the market for insulin pumps market across the globe include Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc, Debiotech S.A, CELLNOVO, SOOIL Developments Co., Ltd, MicroPort Scientific Corporation, Valeritas Inc., F. Hoffmann-La Roche Ltd., Ypsomed AG and among others.

Surgical Suture Market Expected to Deliver Dynamic Progression until 2027

2019-09-18T16:30:44.554Z

Surgical sutures are medical devices that are utilized during the surgical procedures for closing a wound with stitches. Many researchers and market players have developed innovative type of sutures which include absorbable and non-absorbable suture. Sutures are used for stitching the incisions during the surgical procedures or the cuts and wounds occurred during the accidents or injuries. The absorbable sutures are used as they get dissolved in the body with tissue enzymes easily. The advancements in the field of surgical sutures have resulted in increased developments of surgical sutures.

The major players operating in the of surgical sutures in Europe include, B. Braun Melsungen AG, Medtronic, Ethicon USA, LLC, Smith & Nephew, Atramat, Demetech Corporation, Sutures India, Péters Surgical, Teleflex Medical OEM, Serag-Wiessner GmbH & CO. KG among others.

European surgical suture market is estimated to grow at a CAGR of 5.8% during the forecast period from 2018 to 2025. The market for surgical sutures is estimated to reach US$ 1,328.5 Mn in 2025. The market has been witnessing a gradual growth rate during the previous years and is expected to witness similar trend in the coming years. Additionally, manufacturers are focusing towards product innovation in the material used for manufacturing the sutures by means of research and development activities.

In our study, we have segmented the surgical sutures market by product, and application. Based on product, the market is segmented as absorbable sutures and non-absorbable sutures. The absorbable sutures is further classified as natural sutures and synthetic sutures. The application segment is classified as cardiovascular surgeries, orthopedic surgeries, general surgeries, gynecology surgeries, ophthalmic surgeries and others. Geographically, the Europe market for surgical scalpels is segmented into UK, France, Germany, Russia, Italy, Spain, Turkey, Poland and Rest of Europe.

The market for surgical sutures is well established in European market due to rise in the demand for surgical sutures in the region. The market is anticipated to increase during the forecast years owing to factors such as increase in the number of surgical procedures in the region. In the European market United Kingdom holds the largest market for the surgical sutures owing to the factors such as rise in the number of surgeries for the cardiovascular diseases. In addition, British Heart Foundation (BHF) piloted innovative health programs for improvising services for people living with CVD or at risk of CVD. Furthermore, the National Health Service (NHS) in England provided a scheme that helped patients to get benefited with the innovative products. Therrefore, an innovation of plus surgical suture was done that aim to reduce the risk of infection such as Methicillin-resistant Staphylococcus aureus (MRSA) which can cause serious skin infections or infect surgical wounds.

Rerad More@ https://www.theinsightpartners.com/reports/surgical-suture-market

Microbial Identification Panel Market SWOT Analysis and Recent Developments from 2019-2027

2019-09-17T15:43:11.558Z

The global microbial identification panel market accounted to US$ 2,288.7 Mn in 2018 and is expected to grow at a CAGR of 6.2% during the forecast period 2019 – 2027, to account to US$ 3,873.1 Mn by 2027.

In 2018, Asia Pacific accounted as the fastest growing region in the global microbial identification panel market and was projected to grow at a faster pace over the forecast period. The growth of the microbial identification panel market is mostly held by China than in other countries. The increase is widely contributed due to the presence of various pharmaceutical industry and other healthcare industry which are anticipated to use microbial identification panels. In addition, the market in the countries such as Japan and India is estimated to grow due to the growing investment in Japanese Pharmaceutical industry, rising microbial applications in the field of agriculture, food, etc. are likely to influence the growth of the microbial identification panel market. Moreover, the market is expected to have growth opportunities in countries such as South Korea and Australia due to the development of the pharmaceutical and biotechnology secto

Market Insights

Rising Use of Micro-organism for Industrial Applications

Micro-organisms are widely used in the large scale industrial processes. The micro-organisms are used in the production of several metabolites, such as ethanol, butanol, lactic acid, and riboflavin. The micro-organisms are also used for the transformation of chemicals that assist in the reduction of environmental pollution. The micro-organism is also used in other industries such as pharmaceutical, food & agriculture these industries wide range of microbial application. For instance, micro-organisms are used to create biofertilizers or to reduce metal pollutants. The advancement in microbial technology has enabled the use of micro-organisms to produce certain non-microbial products, such as diabetes medication insulin.

In addition, the advancement in technology has helped in the removal of rich genetic resource of non-cultured microorganisms has led to the discovery of new genes, enzymes, and naturally occurring products. The results of the microbial technology have led to the development of most of the commodity and fine chemicals, agrochemicals, and pharmaceuticals. Therefore the discovery of the novel genes, enzymes from the microorganisms has impacted greatly in the production of industrial products through the industrial and biotechnological applications. Therefore, owing to the above-mentioned factors, it is estimated that the rising use of the microorganism for the industrial application is likely to grow the market during the forecast period

Advancement in The Field of Microbiology

Advancement in technologies is rising in rapidly. The rising trend is making the clinical and medical diagnostics much easier. The technological advancement has reduced the time of microbial identification and analyzing procedures. It has also helped in getting outcomes more accurately and efficiently. The next-generation sequencing method has allowed understanding the genetic make-up of micro-organism for various industrial application.

In addition, the advancement in technology has resulted in the rising commercial use of the micro-organisms and has also increased the microbiology field. The advancement has allowed combining the traditional identification kits along with the automated microbial identification systems. For instance, bioMérieux has developed an API system and the Biolog Microbial ID system using a 96-well microplate format. The development in technology has enabled the systems to handle larger numbers of isolates automatically.

Company Profiles

Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Danaher Corporation
bioMérieux
Merck KGaA
Charles River Laboratories, Inc.
Bruker Corporation
Shimadzu Corporation
Avantor (VWR International LLC)
Eurofins Scientific

Moreover, the development in the technologies has resulted into the innovation of various methods for the microbial identification, For instance, protein analysis using Matrix-Assisted Laser Desorption onization-Time of Flight (MALDI-TOF) mass spectrometry and gas chromatography analysis of extracted cellular fatty acids and fatty acid methyl esters (FAMEs) have been developed. These both methods are widely used for the production of commercial products by the pharmaceutical industry. Also, these technologies are being supported by an extensive profile of databases and software. Thus, technology devel

Product & Services Type Insights

The global microbial identification panel market by product & services segments was led by instruments. In 2018, the instruments accounted for the largest market share in the global microbial identification panel market. The growing spending by hospitals, pharmaceutical and food industry on microbial identification activities, are driving the total number of instrument purchased. Therefore, it is expected that instruments market is likely to propel during the forecast period.

Exhibit: South and Central America Microbial Identification Panel Market, by Product & Services

Strategic Insights

Organic and inorganic growth strategies were observed in global microbial identification panel industry. The organic strategies which were conducted more compared to the inorganic strategies for the Microbial Identification Panel. For instance, in June, 2019, Bruker has announced that it has launched MALDI Biotyper Sirius system. The system was launched at ASM Microbe Conference. The system is used for the universal, fast and cost-effective microbial identification from cultures in microbiology.

Microbial Identification Panel – MARKET SEGMENTATION

Global Microbial Identification Panel Market – By Product & Service

Instruments
Automated Microbial Identification Systems
Mass Spectrometers
PCR
Other Instruments
Consumables
Plates and Media
Reagents and Kits
Other Consumables
Software and Services

Global Microbial Identification Panel Market – By Method

Phenotypic
Genotypic
Sanger Sequencing

Next-Generation Sequencing (NGS)
16S/18S/ Internal Transcribed Spacer (ITS) rRNA Sequencing
Metagenomics Sequencing
Antimicrobial Resistance Testing
Other Sequencing
MALDI-TOF

Global Microbial Identification Panel Market – By End User

Hospitals & Diagnostics Laboratories
Pharmaceutical Companies
Other End User

By Geography

North America

U.S.
Canada
Mexico
Europe

France
Germany
UK
Spain
Italy
Asia Pacific (APAC)

China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)

Saudi Arabia
South Africa
UAE
South America (SAM)

Brazil
Argentina

What Are Major Bacterial Diseases Affecting in Aquaculture? What Are Vaccines?

2019-09-04T14:11:31.047Z

Route Of Administration Some fish pathogens may be more common in or adapted to a given species, genus, or family; however, many are ubiquitous and have broad host ranges. Environmental factors, including type of rearing system and production method, influence pathogen variety and prevalence within a given unit and facility. Many pathogens can infect fish regardless of rearing system and production method, but the following sections describe pathogens that may be more problematic under certain conditions.

Most production ponds are outdoor and earthen (dirt or clay lined) and, over time, become high in organic loading as a consequence of feeding, fish growth, waste accumulation, and other related processes. In Florida, smaller ponds facilitate periodic cleaning, whereas much larger catfish ponds in the southeast are logistically much more difficult to clean.

Click Here :- DOWNLOAD PDF OF STUDY

Bacterial and viral diseases are also much more problematic in RASs, partly because microbial flora can be much less diverse and skewed than in more natural pond systems. Mycobacteriosis and streptococcosis have caused significant morbidity and mortality in RASs, which can favor their growth, amplification, and formation of reservoirs. Certain environmental conditions promote mycobacterial growth, including warm water temperatures, low dissolved oxygen levels, acidic pH, high soluble zinc, high fulvic acid, and high humic acid. Many of these conditions—especially the low dissolved oxygen, low pH, and an organically rich environment—are present in intensive aquaculture systems. Closed conditions and higher stocking densities enhance the potential for spread and amplification. Biofilms on the tanks, in pipework, and in filtration systems, as well as organics, inaccessible or overlooked mortalities, and detritus, can serve as reservoirs.

The vaccine is used to establish or improve the immunity against a specific disease or group of diseases. In aquaculture practices, there is always a chance of pathogenic outbreaks, which will affect the production of the farm. Aquaculture vaccines are used to protect the fishes from any pathogen.

Vaccine Type :- Activated Vaccines, Live Vaccines, DNA Vaccines

Application :- Bacterial Infections, Viral infections, Fungal Infections, Parasitic Infections

Species Type :- Sturgeon, Trout, Seabass, Carp, Salmon, Other Species Type

Route Of Administration :- Injection Vaccination, Immersion Vaccination, Spray Vaccination, Oral Vaccination

Aquaculture Vaccines industry including both qualitative and quantitative information. It provides overview and forecast of the global aquaculture vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The aquaculture vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

For Any Inquiry Contact@ http://bit.ly/2ZuEX0d

Medical Recruitment Market SWOT Analysis and Recent Developments from 2019-2027

2019-09-03T12:49:41.295Z

The global medical recruitment market accounted to US$ 8,684.50Mn in 2018 and is expected to grow at a CAGR of 3.2% during the forecast period 2019 – 2027, to account to US$ 11,435.1 Mn by 2027.

Asia Pacific accounted as the fastest growing region in the global medical recruitment market and was projected to grow at a faster pace over the forecast period. The medical recruitment market in the Asia Pacific region is estimated to be fastest growing among all the regions. The growth of the medical recruitment market is expected due to the rising numbers of the medical and other healthcare professional in the countries across the region. The market growth is also expected to grow due to the rising initiatives by the governments for the growth of medical professionals in the countries. Also, the development in the healthcare systems is also responsible for the growth of the market during the forecast period.

Company Profiles:-

Impellam Group
Everyday Health Group
CCM Recruitment International
TFS Healthcare
IMS Recruitment
CPL Healthcare
MASC Medical
Proclinical (ICS)
Euromotion
EGV

Market Insights

Rising Numbers of Healthcare Centers

Health is a significant aspect of quality of life, which directly affects our capacity to enjoy the experience of life and being free from illness or injury, health indirectly affects our capacity to produce and consume other valuable goods and services. The global healthcare sector is growing because as the aging populations, higher prevalence of chronic diseases, exponential advances in innovative, digital technologies these are the factors which continue to increase the health care demand and expenditures.

In US, the American Hospital Association (AHA) is the national organization which represents and serves different types of hospitals, healthcare networks, communities and their patients. Under this organization approximately 5,000 hospitals, healthcare systems, networks and other healthcare providers are included as members. Other than theses approximately 43,000 individual members forms the AHA.

According to the data shared by AHA in the 2018 edition states that, in the year 2016 there were approximately 5,534 hospitals registered in the US. Among the 5,534 hospitals 88% was held by the community hospitals (non-federal acute care), 4% was contributed by the federal government hospitals, 7% by non-federal psychiatric and 1% by the non-federal long term care hospitals. In US, approximately 62% of all community hospitals are in the urban regions. Therefore, it is expected that the significantly rising numbers of healthcare centers are estimated to boost demand for the healthcare professionals during the forecast period.

Growing Super Specialty and Multi-Specialty Hospitals

Multi-specialty hospitals are hospitals offering more than two special treatments in their hospitals whereas, super specialty hospitals offer newer and newer sub specialties for a specific disorder. The physicians in multispecialty hospitals possess degrees as MD medicine, MD dermatology, MS surgery and so on whereas, in super specialty the doctors are super specialists and have degrees like DM neurology, McH urology, DM gastroenterology, McH neurosurgery as in super specialists--who have education higher than a MD/MS.

Multi-specialty hospitals are single doorway to the patients’ health care needs. They offer wide range of treatment from new born to old aged population. These hospitals primarily focus on prevention, disease management and appropriate clinical interventions.

Both multi-specialty and super specialty hospitals provide and promote quality care in health & wellness at an affordable cost to the society. However, super specialty hospitals exist only in some countries and do not exist in other parts of the world. Thus, with growing healthcare needs and rising preference for specialized treatment, the super specialty and multi-specialty hospitals hold several opportunities to grow during the forecast period.

Candidature Insights

The global medical recruitment market by candidature segments was led by health professionals segment. In 2018, the health professionals segment held a largest market share of the medical recruitment market, by candidature. Health professionals has important role to play in increasing the access and quality health care for the population. They offer critical services to promote health, inhibit diseases, and deliver health care services. The services are provided to individuals, families, and communities, which is based on the first health care approach. Therefore, owing to the need and demand of advanced healthcare services, the number of healthcare professionals, it is likely to propel the growth of the market during the forecast period.

Exhibit: South and Central America Medical Recruitment Market, by Candidature

Medical Recruitment – MARKET SEGMENTATION

By Global Medical Recruitment Market – By Candidature

Health Professionals
Physicians
Health Information Technicians
Biological & Medical Scientists
Medical Social Workers
Medical Representatives
Other Candidatures

By Global Medical Recruitment Market – By Service

Managed Services
Consulting Services
Vendor Management
Recruitment Processes Outsourcing (RPO)
Recruitment Services
Permanent Position
Temporary Positio
Specialist Care Services
Homecare Services
Other Services

By Geography

North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
South America (SAM)

Strategic Insights:-

Organic growth strategies were observed in global medical recruitment industry. The organic strategies which were conducted by the various market players in the medical recruitment market. For instance, in May 2019, Proclinical AG has expanded its presence to Basel. The company has utilized this strategy as opportunity to mark its presence. Also, rising demand for skilled R&D professionals from biopharmaceutical, pharmaceutical, medical device and clinical research organizations has enforced to use this strategy for growth in the market.

Embolotherapy Market With Innovations, Competitive Analysis and New Business Developments, Trends during Forecast Period

2019-08-30T15:06:31.950Z

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gelfoam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

MARKET DYNAMICS

The market for embolotherapy is forecasted to grow during the forecast years due to growing burden of target diseases, rising investments and technological advancements, growing investments by private players to develop innovative products and implants. Furthermore, rising demand for minimally invasive procedures, favorable reimbursement scenario for minimally invasive surgeries. The market is expected to experience several growth opportunities due to development in technology that enable to utilize different innovative materials for the embolotherapy in coming future.

MARKET SCOPE

The "Global Embolotherapy Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy market with detailed market segmentation by product, disease indication, procedure, end user and geography. The global Embolotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Embolotherapy market players and offers key trends and opportunities in the market.

MARKET PLAYERS

The reports cover key developments in the Embolotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Embolotherapy market are anticipated to lucrative growth opportunities in the future with the rising demand for Embolotherapy market in the global market. Below mentioned is the list of few companies engaged in the Embolotherapy market.

The report also includes the profiles of key Embolotherapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories
- Acandis GmbH
- Balt Extrusion
- Boston Scientific Corporation
- BTG PLC
- Cook Medical
- Johnson & Johnson
- Kaneka Corporation
- Medtronic PLC
- Meril Life Sciences Pvt., Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

MARKET SEGMENTATION

The global Embolotherapy market is segmented on the basis of product, disease indication, procedure, and end user. Based on the product the market is segmented as Embolic Agents, and Support Devices. Embolic agents segment is further sub segmented into, Microspheres, Embolic Coils Liquid Embolic Agents, Embolic Plug Systems, and Detachable Balloons. Support Devices is sub segmented into Microcatheters and Guidewires. On the basis of disease indication, embolotherapy market is classified as Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders and Gastrointestinal Disorders. Based on the procedure, the market is segmented as Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) and Transarterial Chemoembolization (TACE). On the basis of end user, the market is segmented into Hospitals and Clinics, Ambulatory Surgery Centers, and Other End Users

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Embolotherapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Embolotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Embolotherapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Embolotherapy market in these regions.

Cytotoxic Drugs Market Detailed In New Research Report 2019

2019-08-30T14:53:03.925Z

Cytotoxic drugs are used for the destruction of tumors, reduce the metastasis of cancer and alleviate cancer symptoms. These drugs also helps to improve the outcomes of surgery. Cytotoxic drugs are effective on all the dividing cells in the body, including the non-cancerous cells, however this effect is less pronounced and healthy cells are recovered faster.

MARKET DYNAMICS

The cytotoxic drugs market is anticipated to grow in the forecast, owing to increasing prevalence of cancer across the globe, development of cutting edge therapeutic modalities by market players, and others. However, risk of cytotoxic drugs to show adverse effects on non-cancerous cells is likely to refrain the growth of the market.

MARKET SCOPE

The "Global Cytotoxic Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of cytotoxic drugs market with detailed market segmentation by drug type, route of administration, distribution channel, and geography. The global cytotoxic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cytotoxic drugs market players and offers key trends and opportunities in the market.

MARKET PLAYERS

The reports cover key developments in the cytotoxic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cytotoxic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for cytotoxic drugs market in the global market. Below mentioned is the list of few companies engaged in the cytotoxic drugs market.

The report also includes the profiles of key cytotoxic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Merck KGaA
- Celgene
- Eli Lilly and Company
- Sanofi
- Pfizer, Inc.
- GlaxoSmithKline Plc
- Johnson and Johnson Services, Inc.
- Amgen
- F.Hoffmann La-Roche Ltd.
- Lonza
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

MARKET SEGMENTATION

The global cytotoxic drugs market is segmented on the basis of drug type, route of administration, and distribution channel. Based on drug type, the market is segmented as alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others. Based on route of administration, the market is segmented into intravenous, and oral. On the basis of distribution channel, the global cytotoxic drugs market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cytotoxic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cytotoxic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cytotoxic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cytotoxic drugs market in these regions.

Read More@ https://www.theinsightpartners.com/reports/cytotoxic-drugs-market